<DOC>
	<DOCNO>NCT02070536</DOCNO>
	<brief_summary>Current clinical prediction score acute respiratory distress syndrome ( ARDS ) limit positive predictive value . No study evaluate predictive kinetics plasma biomarkers receptor advanced glycation end product ( RAGE ) polymorphisms broad population critically ill patient adjunct clinical prediction score . The main objective investigator study evaluate predictive value plasma soluble RAGE level onset ARDS high risk population patient admit intensive care unit ( ICU ) . One investigator goal improve early identification patient risk ARDS order well implement preventive stategies prior ARDS development . The primary outcome occurrence ARDS first week admission ICU .</brief_summary>
	<brief_title>Predictive Values Plasma Soluble RAGE Levels RAGE Polymorphisms Onset Acute Respiratory Distress Syndrome Critically Ill Patients</brief_title>
	<detailed_description>BACKGROUND : ARDS major cause morbidity mortality critically ill patient . Only pharmacological treatment available , limited evidence efficacy . The development efficient preventive stategies limit investigator inability predict patient likely develop ARDS . The Lung Injury predicition Score ( LIPS ) develop identify patient high risk ARDS , predictive value remain limited . The receptor advance glycation end product ( RAGE ) identify marker alveolar type I cell injury . RAGE member immunoglobulin superfamily act multiligand receptor involve propagate inflammatory response . Plasma level sRAGE correlate clinical radiologic severity ARDS patient . The investigator main objective ass predictive value plasma sRAGE esRAGE level , well evolution first 24 hour admission , onset ARDS high risk patient . The secondary objective : - evaluate predictive value RAGE polymorphism ( _429 T/C , _374 T/A , 2184 A/G , Gly82Ser ) onset ARDS - evaluate predictive value maximal plasma level RAGE soluble form onset ARDS - test relationship RAGE polymorphism plasma sRAGE esRAGE level - test whether serial sRAGE measurement would improve discrimination LIP Score - evaluate prognostic value plasma level RAGE soluble form : duration mechanical ventilation , length stay ICU 30-day mortality . DESIGN NARRATIVE : The purpose prospective observational study test value RAGE polymorphism soluble form plasma level ARDS prediction high risk ICU patient</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<criteria>Patients admit ICU Patients present risk factor ARDS : high risk surgery , sepsis , shock , panceatitis , pneumonia , aspiration , drown , massive transfusion , pulmonary contusion , serious burn , severe trauma . Informed consent Pregnancy Age &lt; 18 year Criteria ARDS admission ICU Expected survival 48 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Acute Respiratory Distress Syndrome ( ARDS )</keyword>
	<keyword>Receptor advance glycation end product ( RAGE )</keyword>
	<keyword>Soluble RAGE ( sRAGE )</keyword>
	<keyword>Gene polymorphism</keyword>
	<keyword>Biomarker</keyword>
</DOC>